Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23085581 | 0.92 | KDM1A (0.40) | KDM1AMEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL28164961 | 0.92 | KDM1A (0.40) | KDM1AMEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL27320258 | 0.90 | CHRM5 (0.39) | KDM1AMEN1KMT2ACHRNB2CHRNA7 | |
| SCHEMBL19457103 | 0.88 | — | — | |
| SCHEMBL14899968 | 0.86 | KDM1A (0.35) | KDM1AMEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL5752748 | 0.83 | — | — | |
| SCHEMBL12632397 | 0.83 | — | — | |
| SCHEMBL6047335 | 0.74 | — | — | |
| SCHEMBL14823372 | 0.72 | CHRM5 (0.38) | MEN1CYP2D6CYP2C19KMT2ACHRNB2 | |
| SCHEMBL7625537 | 0.72 | KDM1A (0.39) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253533-A1 | DISUBSTITUTED 5(3)-PYRAZOLE CARBOXYLATES AND A PROCESS FOR THEIR PREPARATION FROM ENOLATES AND FLUOROALKYLAMINOREAGENTS (FAR) REAGENTS | BAYER AG (DE) | 2021-08-19 | — | — | US | claimed |
| EP-3807250-A1 | DISUBSTITUTED 5(3)-PYRAZOLE CARBOXYLATES AND A PROCESS FOR THEIR PREPARATION FROM ENOLATES AND FLUOROALKYLAMINOREAGENTS (FAR) REAGENTS | Bayer Aktiengesellschaft (DE) | 2021-04-21 | — | — | EP | claimed |
| WO-2019243179-A1 | DISUBSTITUTED 5(3)-PYRAZOLE CARBOXYLATES AND A PROCESS FOR THEIR PREPARATION FROM ENOLATES AND FLUOROALKYLAMINOREAGENTS (FAR) REAGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2019-12-26 | — | — | WO | claimed |
| EP-2707373-A1 | BICYCLIC (THIO)CARBONYLAMIDINES | Bayer Intellectual Property GmbH (DE) | 2014-03-19 | — | — | EP | claimed |
| WO-2012152741-A1 | BICYCLIC (THIO)CARBONYLAMIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-11-15 | — | — | WO | claimed |
| WO-2011009026-A1 | FUNCTIONALIZED CARBON NANOSTRUCTURES WHICH ARE SOLUBLE IN HYDROCARBONS AND METHOD FOR PREPARATION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-01-20 | — | — | WO | claimed |
| EP-1945748-A4 | METALS COMPATIBLE PHOTORESIST AND/OR SACRIFICIAL ANTIREFLECTIVE COATING REMOVAL COMPOSITION | ADVANCED TECH MATERIALS (US) | 2009-01-07 | — | — | EP | claimed |
| EP-1949424-A2 | COMPOSITION AND METHOD FOR SELECTIVELY ETCHING GATE SPACER OXIDE MATERIAL | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2008-07-30 | — | — | EP | claimed |
| EP-1945748-A2 | METALS COMPATIBLE PHOTORESIST AND/OR SACRIFICIAL ANTIREFLECTIVE COATING REMOVAL COMPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2008-07-23 | — | — | EP | claimed |
| WO-2007047365-A2 | METALS COMPATIBLE PHOTORESIST AND/OR SACRIFICIAL ANTIREFLECTIVE COATING REMOVAL COMPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| WO-2007044447-A2 | COMPOSITION AND METHOD FOR SELECTIVELY ETCHING GATE SPACER OXIDE MATERIAL | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2007-04-19 | — | — | WO | claimed |
| WO-2007027522-A2 | COMPOSITION AND METHOD FOR REMOVING THICK FILM PHOTORESIST | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2007-03-08 | — | — | WO | claimed |
| EP-3750928-B1 | ACRYLIC COPOLYMER, PREPARATION METHOD THEREFOR, AND ACRYLIC COPOLYMER COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2024-02-21 | — | — | EP | disclosed |
| WO-2023162975-A1 | SEALING RESIN COMPOSITION AND SEMICONDUCTOR DEVICE | 住友ベークライト株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023117914-A1 | CYCLOPENTATHIOPHENE CARBOXAMIDE DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2022202434-A1 | CONDUCTIVE PASTE, AND SEMICONDUCTOR DEVICE | 住友ベークライト株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2000064858-A1 | BIPOLAR LIPIDS AND THEIR USE FOR THE DELIVERY OF BIOACTIVE SUBSTANCES | CELLTECH R&D LIMITED (GB) | 2000-11-02 | — | — | WO | disclosed |
| EP-0871630-A1 | 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO 3,4':4,5]FURO(3,2-b)PYRIDINE-6,8 7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES | BAYER AG (DE) | 1998-10-21 | — | — | EP | disclosed |
| EP-0866074-A1 | NOVEL NK374186 ANALOGUES OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1998-09-23 | — | — | EP | disclosed |
| WO-1997014695-A1 | 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO[3,4':4,5]FURO(3,2-b)PYRIDINE-6,8[7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253533-A1 | DISUBSTITUTED 5(3)-PYRAZOLE CARBOXYLATES AND A PROCESS FOR THEIR PREPARATION FROM ENOLATES AND FLUOROALKYLAMINOREAGENTS (FAR) REAGENTS | FAR1, CBR3, AFF4 | KDM1A 2801/4885MEN1 1389/4885CYP2D6 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.